Stéphane Minvielle

10PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical mycologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 03, 2026
Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

|Aug 15, 2024
Role and timing of chromosome deletions in multiple myeloma.

Stéphane Minvielle, Eric Letouzé

|Dec 14, 2023
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.

Romane Durand, Géraldine Descamps, Céline Bellanger

|Jul 31, 2023
Exploring the impact of dexamethasone on gene regulation in myeloma cells.

Victor Bessonneau-Gaborit, Jonathan Cruard, Catherine Guerin-Charbonnel

|Jan 05, 2023
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

Mehmet Kemal Samur, Marco Roncador, Anil Aktas Samur

Pageof 2

Frequent Collaborators

3 joint publications

Jill Corre

3 joint publications

Aurore Perrot

2 joint publications

Eric Letouzé

2 joint publications

Cyrille Touzeau